Cambridge Cognition Holdings Plc (AIM:COG)
London · Delayed Price · Currency is GBP · Price in GBX 34.50
-1.00 (-2.82%)
Mar 26, 2026, 3:43 PM GMT
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 14.44 million as of March 26, 2026. Its market cap has decreased by -12.18% in one year.
Market Cap
14.44M
Enterprise Value
15.51M
Revenue
9.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.50
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has increased from 13.12M to 14.44M, an increase of 10.11%. That is a compound annual growth rate of 0.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 14.86M | 26.79% |
| Dec 31, 2025 | 11.72M | -24.92% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.19B |
| GSK plc | 79.07B |
| Haleon | 32.06B |
| Smith & Nephew | 10.24B |
| SkinBioTherapeutics | 20.34M |
| Inspiration Healthcare Group | 18.11M |
| Aptamer Group | 17.53M |
| genedrive | 16.86M |